Veterinary Medicine Information website

Fatroximin, 100 mg/13,4g, intrauteriinvaht hobustele, kelle liha ei tarvitata inimtoiduks ja veistele

Authorised
  • Rifaximin
Download as PDF

Product identification

Medicine name:
Fatroximin, 100 mg/13,4g, intrauteriinvaht hobustele, kelle liha ei tarvitata inimtoiduks ja veistele
Active substance:
  • Rifaximin
Target species:
  • Horse (non food-producing)
  • Cattle
Route of administration:
  • Intrauterine use

Product details

Active substance and strength:
  • Rifaximin
    100.00
    milligram(s)
    /
    13.40
    gram(s)
Pharmaceutical form:
  • Intrauterine foam
Withdrawal period by route of administration:
  • Intrauterine use
    • Horse (non food-producing)
      • Milk
        no withdrawal period
    • Cattle
      • Meat and offal
        0
        day
      • Milk
        0
        hour
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QG51AA06
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Estonia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Fatro S.p.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Fatro S.p.A.
Responsible authority:
  • State Agency Of Medicines
Authorisation number:
  • 1107
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Estonian (PDF)
Published on: 17/09/2025
Download